Clinical profile and management of pleomorphic adenoma of head neck: our experience
Keywords:Pleomorphic adenoma, Head neck, Surgical excision, Squamous cell carcinoma, Mucoepidermoid carcinoma, Warthin's tumor, Serous cystadenocarcinoma
Background: Pleomorphic adenoma constitutes one of the common salivary gland tumors. Our aim is to study the clinical presentation of pleomorphic adenoma, preoperative and postoperative histopathological findings and management of tumors.
Methods: A retrospective study of 43 patients was conducted at department of ENT, Government Medical College and Hospital, Nagpur between January 2017 to February 2019. Data was collected and analysed.
Results: Maximum patients were of age group 40-60 years with male preponderance. Parotid being most common gland involved, 35 cases of all 43 were post-operatively confirmed to be pleomorphic adenoma.
Conclusions: Pleomorphic adenoma is most commonly diagnosed in age group 40-60 years. Surgical excision is treatment of choice. Long term follow-up of the cases is warranted owing to risk of late recurrences.
Mc Loughlin L, Gillanders SL, Smith S, Young O. The role of adjuvant radiotherapy in management of recurrent pleomorphic adenoma of the parotid gland: a systematic review. Eur Arch Otorhinolaryngol. 2019;276(2):283-95.
Lee JH, Kang HJ, Yoo CW, Park WS, Ryu JS, Jung YS, et al. PLAG1, SOX10, and Myb Expression in Benign and Malignant Salivary Gland Neoplasms. J Pathol Transl Med. 2019;53(1):23-30.
Meshram GG, Kaur N, Hura KS. Pediatric Pleomorphic Adenoma of the Parotid: Case Report, Review of Literature and Novel Therapeutic Targets. Children (Basel). 2018;5(9):127.
Rose GE. Pleomorphic adenoma of the lacrimal gland. Br J Ophthalmol.1992;76:395–400.
Krysten C. Etiology and familial inheritance of pleomorphic adenomas. Dentistry 3000. 2017;5(1):54-8.
Martinelli M, Martini F, Rinaldi E, Caramanico L, Magri E, Grandi E, et al. Simian virus 40 sequences and expression of the viral large T antigen oncoprotein in human pleomorphic adenomas of parotid glands. Am J Pathol. 2002;161(4):1127–33.
Mendenhall WM, Mendenhall CM, Werning JW, Malyapa RS, Mendenhall NP. Salivary gland pleomorphic adenoma. Am J Clin Oncol. 2008;31(1):95–9.
Krolls SO, Boyers RC. Mixed tumor of salivary glands. Long-term follow-up. Cancer. 1972;30(1):276–81.
Valstar MH, de Ridder M, van den Broek EC, Stuiver MM, van Dijk BAC, van Velthuysen MLF, et al. Salivary gland pleomorphic adenoma in the Netherlands: a nationwide observational study of primary tumor incidence, malignant transformation, recurrence, and risk factors for recurrence. Oral Oncol. 2017;66:93-9.
Aro K, Valle J, Tarkkanen J, Mäkitie A, Atula T. Repeatedly recurring pleomorphic adenoma: a therapeutic challenge. Acta Otorhinolaryngol Ital. 2019;39(3):156–61.
Gleave EN, Whittaker JS, Nicholson A. Salivary tumours–experience over thirty years. Clin Otolaryngol Allied Sci. 1979;4:247–57.
Sarmento DJ, Morais ML, Costa AL, Silveira EJ. Minor intraoral salivary gland tumors: a clinical-pathological study. Einstien (Sao Paulo). 2016;14(4):508-12.
Chang EZ, Lee WC. Surgical treatment of salivary gland tumors. J Oral Maxillofac Surg. 1989;47(6):555–8.
Wu YC, Wang YP, Cheng SJ, Chen HM, Sun A, Chang JY. Clinicopathological Study of 74 Palatal Pleomorphic Adenomas. J Formosan Med Assoc. 2016;115(1):25-30.